Multidrug-resistant (MDR) A. baumannii is a rapidly emerging pathogen in healthcare settings, where it causes infections that include bacteremia, pneumonia, meningitis, and urinary tract and wound ...

Infections by multidrug resistant organisms (MDROs) are a global health threat with a worrying increasing trend. In fragile ...

The following is a summary of “Carbapenemase production and in-hospital mortality associated with multidrug-resistant ...

Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the ...

Progress in understanding the molecular basis of drug resistance in cancer promises more effective treatments. Multidrug resistance, the principal mechanism by which many cancers develop ...

Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, give new options for shorter, personalized treatment ...

Cyprus has recorded a 275.5 per cent increase in bloodstream infections caused by Enterobacterales resistant to carbapenem antibiotics, placing it fourth among EU countries facing this growing ...

Disparate pathogenic mechanisms complicate precision-medicine efforts to treat diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis. Though potentially curable with frontline ...

A tuberculosis (TB) patient is said to be multidrug-resistant when the bacteria strain causing the infection has become ...

Multidrug-resistance is a significant challenge in eliminating the bacterial disease, as the complication increases treatment ...

Studies show under-representation of children and teens with multidrug-resistant TB, calling for focused case-finding efforts ...